Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jihao Zhou

Showing results (11-20 of 48) with videos related to

Pageof 5
Sort By:
American Journal of Clinical Pathology|August 22, 2019
An Uncommon Case of Double-Hit Mantle Cell Lymphoma That Demonstrates a Transformation ProcessJihao Zhou, Lina Hu, Min Zuo, et al.
Contemporary Clinical Trials Communications|July 14, 2018
Seamless phase IIa/IIb adaptive design with the same primary endpoint for proof of concept and dose findingJiacheng Yuan, Daniel Radecki, Denise Bugarin, et al.
Neurourology and Urodynamics|February 26, 2011
Urodynamic results and clinical outcomes with intradetrusor injections of onabotulinumtoxinA in a randomized, placebo-controlled dose-finding study in idiopathic overactive bladderEric Rovner, Michael Kennelly, Heinrich Schulte-Baukloh, et al.
Anti-Cancer Drugs|March 8, 2006
Effect of food on the pharmacokinetics of sunitinib malate (SU11248), a multi-targeted receptor tyrosine kinase inhibitor: results from a phase I study in healthy subjectsCarlo L Bello, Laurie Sherman, Jihao Zhou, et al.
Journal of Biopharmaceutical Statistics|February 26, 2010
Drug-drug interaction prediction assessmentJihao Zhou, Zhaohui Qin, Quinney K Sara, et al.
International Urogynecology Journal|January 26, 2012
Treatment satisfaction and goal attainment with onabotulinumtoxinA in patients with incontinence due to idiopathic OABLinda Brubaker, Angelo Gousse, Peter Sand, et al.
Hematology (Amsterdam, Netherlands)|January 8, 2020
Donor CMV-specific cytotoxic T lymphocytes successfully treated drug-resistant cytomegalovirus encephalitis after allogeneic hematopoietic stem cell transplantationPeng Ke, Xiebing Bao, Jihao Zhou, et al.
Frontiers in Immunology|November 24, 2025
Case Report: Severe autoimmune hemolytic anemia in an elderly patient caused by warm-reactive IgG and IgA autoantibodiesWenxia Xia, Jialing Lu, Junjie Hou, et al.
Plos One|August 14, 2013
Increased PRAME-specific CTL killing of acute myeloid leukemia cells by either a novel histone deacetylase inhibitor chidamide alone or combined treatment with decitabineYushi Yao, Jihao Zhou, Lixin Wang, et al.
Transfusion|May 27, 2025
Establishment and application of a new method for the detection of drug antibodies by flow cytometryYanlian Liang, Wenqiang Qu, Jialing Lu, et al.
Pageof 5

Showing results (11-20 of 48) with videos related to

Sort By:
Pageof 5
American Journal of Clinical Pathology|August 22, 2019
An Uncommon Case of Double-Hit Mantle Cell Lymphoma That Demonstrates a Transformation ProcessJihao Zhou, Lina Hu, Min Zuo, et al.
Contemporary Clinical Trials Communications|July 14, 2018
Seamless phase IIa/IIb adaptive design with the same primary endpoint for proof of concept and dose findingJiacheng Yuan, Daniel Radecki, Denise Bugarin, et al.
Neurourology and Urodynamics|February 26, 2011
Urodynamic results and clinical outcomes with intradetrusor injections of onabotulinumtoxinA in a randomized, placebo-controlled dose-finding study in idiopathic overactive bladderEric Rovner, Michael Kennelly, Heinrich Schulte-Baukloh, et al.
Anti-Cancer Drugs|March 8, 2006
Effect of food on the pharmacokinetics of sunitinib malate (SU11248), a multi-targeted receptor tyrosine kinase inhibitor: results from a phase I study in healthy subjectsCarlo L Bello, Laurie Sherman, Jihao Zhou, et al.
Journal of Biopharmaceutical Statistics|February 26, 2010
Drug-drug interaction prediction assessmentJihao Zhou, Zhaohui Qin, Quinney K Sara, et al.
International Urogynecology Journal|January 26, 2012
Treatment satisfaction and goal attainment with onabotulinumtoxinA in patients with incontinence due to idiopathic OABLinda Brubaker, Angelo Gousse, Peter Sand, et al.
Hematology (Amsterdam, Netherlands)|January 8, 2020
Donor CMV-specific cytotoxic T lymphocytes successfully treated drug-resistant cytomegalovirus encephalitis after allogeneic hematopoietic stem cell transplantationPeng Ke, Xiebing Bao, Jihao Zhou, et al.
Frontiers in Immunology|November 24, 2025
Case Report: Severe autoimmune hemolytic anemia in an elderly patient caused by warm-reactive IgG and IgA autoantibodiesWenxia Xia, Jialing Lu, Junjie Hou, et al.
Plos One|August 14, 2013
Increased PRAME-specific CTL killing of acute myeloid leukemia cells by either a novel histone deacetylase inhibitor chidamide alone or combined treatment with decitabineYushi Yao, Jihao Zhou, Lixin Wang, et al.
Transfusion|May 27, 2025
Establishment and application of a new method for the detection of drug antibodies by flow cytometryYanlian Liang, Wenqiang Qu, Jialing Lu, et al.
Pageof 5